GENERAL PURPOSE ACQUISITION (GPACU) Fundamental Analysis & Valuation

NASDAQ:GPACU • KYG3810N1227

Current stock price

10.02 USD
-0.01 (-0.1%)
Last:

This GPACU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GPACU Profitability Analysis

1.1 Basic Checks

  • In the past year GPACU has reported negative net income.
  • In the past year GPACU has reported a negative cash flow from operations.
  • In multiple years GPACU reported negative net income over the last 5 years.
  • GPACU had a negative operating cash flow in each of the past 5 years.
GPACU Yearly Net Income VS EBIT VS OCF VS FCFGPACU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • GPACU has a worse Return On Assets (-236.61%) than 89.01% of its industry peers.
Industry RankSector Rank
ROA -236.61%
ROE N/A
ROIC N/A
ROA(3y)-127.92%
ROA(5y)-77.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GPACU Yearly ROA, ROE, ROICGPACU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GPACU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GPACU Yearly Profit, Operating, Gross MarginsGPACU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

1

2. GPACU Health Analysis

2.1 Basic Checks

  • GPACU has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for GPACU has been reduced compared to a year ago.
GPACU Yearly Shares OutstandingGPACU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
GPACU Yearly Total Debt VS Total AssetsGPACU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -11.69, we must say that GPACU is in the distress zone and has some risk of bankruptcy.
  • GPACU's Altman-Z score of -11.69 is on the low side compared to the rest of the industry. GPACU is outperformed by 81.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.69
ROIC/WACCN/A
WACCN/A
GPACU Yearly LT Debt VS Equity VS FCFGPACU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 0.17 indicates that GPACU may have some problems paying its short term obligations.
  • The Current ratio of GPACU (0.17) is worse than 89.01% of its industry peers.
  • GPACU has a Quick Ratio of 0.17. This is a bad value and indicates that GPACU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GPACU has a worse Quick ratio (0.17) than 87.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
GPACU Yearly Current Assets VS Current LiabilitesGPACU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

1

3. GPACU Growth Analysis

3.1 Past

  • The earnings per share for GPACU have decreased strongly by -539.60% in the last year.
EPS 1Y (TTM)-539.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, GPACU will show a very strong growth in Earnings Per Share. The EPS will grow by 23.14% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y59.81%
EPS Next 2Y33.73%
EPS Next 3Y23.14%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GPACU Yearly Revenue VS EstimatesGPACU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 50M 100M 150M 200M
GPACU Yearly EPS VS EstimatesGPACU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -1 -2 -3 -4 -5

1

4. GPACU Valuation Analysis

4.1 Price/Earnings Ratio

  • GPACU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GPACU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GPACU Price Earnings VS Forward Price EarningsGPACU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GPACU Per share dataGPACU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GPACU's earnings are expected to grow with 23.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.73%
EPS Next 3Y23.14%

0

5. GPACU Dividend Analysis

5.1 Amount

  • No dividends for GPACU!.
Industry RankSector Rank
Dividend Yield 0%

GPACU Fundamentals: All Metrics, Ratios and Statistics

GENERAL PURPOSE ACQUISITION

NASDAQ:GPACU (3/19/2026, 8:04:22 PM)

10.02

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners3.98%
Inst Owner ChangeN/A
Ins Owners30.75%
Ins Owner ChangeN/A
Market Cap98.90M
Revenue(TTM)N/A
Net Income(TTM)-23.75M
Analysts80
Price Target57.87 (477.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.75%
Min EPS beat(2)-27.45%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-59.54%
Min EPS beat(4)-175.41%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.69%
PT rev (3m)4.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)-44.64%
EPS NY rev (3m)-44.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.32
EYN/A
EPS(NY)-1.12
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0
BVpS-0.44
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -236.61%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-127.92%
ROA(5y)-77.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -11.69
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-539.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.36%
EPS Next Y59.81%
EPS Next 2Y33.73%
EPS Next 3Y23.14%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-571.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.13%
EBIT Next 3Y8.63%
EBIT Next 5YN/A
FCF growth 1Y-541.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-541.38%
OCF growth 3YN/A
OCF growth 5YN/A

GENERAL PURPOSE ACQUISITION / GPACU Fundamental Analysis FAQ

What is the fundamental rating for GPACU stock?

ChartMill assigns a fundamental rating of 1 / 10 to GPACU.


What is the valuation status for GPACU stock?

ChartMill assigns a valuation rating of 1 / 10 to GENERAL PURPOSE ACQUISITION (GPACU). This can be considered as Overvalued.


What is the profitability of GPACU stock?

GENERAL PURPOSE ACQUISITION (GPACU) has a profitability rating of 0 / 10.


What is the financial health of GENERAL PURPOSE ACQUISITION (GPACU) stock?

The financial health rating of GENERAL PURPOSE ACQUISITION (GPACU) is 1 / 10.


Can you provide the expected EPS growth for GPACU stock?

The Earnings per Share (EPS) of GENERAL PURPOSE ACQUISITION (GPACU) is expected to grow by 59.81% in the next year.